CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 265 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $47,000 | – | 11,464 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 153,391 | $2,376 | 5.62% |
| GABLES CAPITAL MANAGEMENT INC. | 432,210 | $6,694,934 | 3.50% |
| Altium Capital Management LP | 500,000 | $7,745,000 | 3.16% |
| JW Asset Management, LLC | 413,392 | $6,403,442 | 2.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,127,305 | $141,381,954 | 2.35% |
| Opaleye Management Inc. | 640,000 | $9,913,600 | 2.26% |
| BRIDGER MANAGEMENT, LLC | 184,527 | $2,858,323 | 1.47% |
| Ikarian Capital, LLC | 518,386 | $8,029,799 | 1.40% |
| QSV Equity Investors LLC | 84,137 | $1,303,282 | 1.36% |
| Knott David M Jr | 212,000 | $3,284 | 1.31% |